Egetis comments on market rumors
March 30, 2023
Stockholm, Sweden, March 30, 2023. In light of existing rumors in the market the Board of Directors of Egetis Therapeutics AB (publ) (STO: EGTX) wishes to make the following statement:
Egetis Therapeutics has ongoing discussions with certain external parties regarding a potential acquisition of the company. There can be no certainty that a public take-over offer will be made, nor as to the terms of any such offer.